Unresectable Melanoma
📧 Sign up to get email alerts when something new happens for Unresectable Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) [Phase 2]
A Phase 2 trial evaluating Acasunlimab alone and in combination with pembrolizumab for advanced melanoma that has relapsed after prior check…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. [Phase 3]
Phase 3 trial evaluating lifileucel plus pembrolizumab versus pembrolizumab alone in untreated advanced melanoma (metastatic/unresectable); …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of the IL-6 receptor inhibitor sarilumab with ipilimumab, nivolumab, and relatlimab f…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) [Phase 3]
Phase 3 trial evaluating IO102-IO103 in combination with pembrolizumab versus pembrolizumab alone in advanced/metastatic/unresectable melano…